Level Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-174
Closed -$50.1K 83
2023
Q4
$50.1K Hold
174
0.02% 112
2023
Q3
$46.8K Buy
174
+100
+135% +$25K 0.03% 112
2023
Q2
$16.4K Hold
74
0.01% 161
2023
Q1
$17.9K Sell
74
-3
-4% -$736 0.01% 142
2022
Q4
$20K Buy
77
+3
+4% +$804 0.01% 128
2022
Q3
$17K Hold
74
0.01% 146
2022
Q2
$18K Hold
74
0.01% 151
2022
Q1
$18K Sell
74
-100
-57% -$23K 0.01% 132
2021
Q4
$39K Buy
+174
New +$36.7K 0.03% 109

Other funds holding AMGN

Level Financial Advisors's AMGN Position: Q1 2024 in Review

Level Financial Advisors sold out of Amgen (AMGN) in Q1 2024, closing a stake of 174 shares — an estimated $50.1K sold.

Level Financial Advisors first reported a position in AMGN in Q4 2021 and held it in 9 quarters. The position peaked at $50.1K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Level Financial Advisors reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Level Financial Advisors sold 174 Amgen shares in Q1 2024, an estimated $50.1K.
  • Level Financial Advisors first reported a position in Amgen in Q4 2021 and held it in 9 quarters.
  • Level Financial Advisors's Amgen position peaked at $50.1K in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Level Financial Advisors's 13F filing for Q1 2024, filed 19 Apr 2024.